These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 6876429

  • 21. Phase II evaluation of topotecan for pediatric central nervous system tumors.
    Blaney SM, Phillips PC, Packer RJ, Heideman RL, Berg SL, Adamson PC, Allen JC, Sallan SE, Jakacki RI, Lange BJ, Reaman GH, Horowitz ME, Poplack DG, Balis FM.
    Cancer; 1996 Aug 01; 78(3):527-31. PubMed ID: 8697400
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K, Taguchi H, Sawamura Y, Ikeda J, Aoyama H, Fujieda K, Ishii N, Kashiwamura M, Iwasaki Y, Shirato H.
    Jpn J Clin Oncol; 2008 Jul 01; 38(7):486-92. PubMed ID: 18573848
    [Abstract] [Full Text] [Related]

  • 28. [Effect of interferon on malignant brain tumor].
    Wakabayashi T, Yoshida J, Kobayashi T, Kageyama N, Kanzaki M.
    Gan To Kagaku Ryoho; 1982 Aug 01; 9(8):1400-6. PubMed ID: 7184455
    [Abstract] [Full Text] [Related]

  • 29. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y.
    Pediatr Blood Cancer; 2004 Jul 01; 43(1):46-54. PubMed ID: 15170889
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.
    Martell LA, Agrawal A, Ross DA, Muraszko KM.
    Cancer Res; 1993 Mar 15; 53(6):1348-53. PubMed ID: 8443815
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of intratumoral administration of tumor necrosis factor-alpha in patients with malignant glioma.
    Oshiro S, Tsugu H, Komatsu F, Ohnishi H, Ueno Y, Sakamoto S, Fukushima T, Soma G.
    Anticancer Res; 2006 Mar 15; 26(6A):4027-32. PubMed ID: 17195453
    [Abstract] [Full Text] [Related]

  • 32. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Therapeutic effect of human lymphoblastoid interferon (MOR-22) on malignant brain tumors--a phase II study].
    Hirakawa K.
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun 20; 21(5):1068-74. PubMed ID: 3760650
    [No Abstract] [Full Text] [Related]

  • 36. High concentration of locally administered human fibroblast interferon in a glioblastoma multiforme. Discrepancy between clinical response and sensitivity of the tumor cells to the interferon in vitro.
    Fukui M, Sawa H, Takeshita I, Kitamura K, Satoh Y, Kasama K.
    Fukuoka Igaku Zasshi; 1986 Feb 20; 77(2):135-43. PubMed ID: 3011624
    [No Abstract] [Full Text] [Related]

  • 37. Relation between Irofulven (MGI-114) systemic exposure and tumor response in human solid tumor xenografts.
    Leggas M, Stewart CF, Woo MH, Fouladi M, Cheshire PJ, Peterson JK, Friedman HS, Billups C, Houghton PJ.
    Clin Cancer Res; 2002 Sep 20; 8(9):3000-7. PubMed ID: 12231547
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Current status and problems of cancer treatment with interferon].
    Ichikawa H.
    Gan No Rinsho; 1983 May 20; 29(6):616-9. PubMed ID: 6876430
    [Abstract] [Full Text] [Related]

  • 40. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T.
    Hepatogastroenterology; 1998 May 20; 45(24):2282-94. PubMed ID: 9951911
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.